Cite
HARVARD Citation
Lin, D. et al. (2022). Real-world data on the comparison of LDL-C lowering effects between alirocumab and evolocumab. Atherosclerosis. pp. 218-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lin, D. et al. (2022). Real-world data on the comparison of LDL-C lowering effects between alirocumab and evolocumab. Atherosclerosis. pp. 218-. [Online].